Endometriosis Trial, Recruiting NCT06671639 Sponsor: Stanford University Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06671639
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 6 and 21 years old and weigh at least 15 kilograms (about 33 pounds)
  • You have a medical condition for which the surgery being studied has been chosen as the right treatment by your guardian and surgeon
  • You have never previously had surgery using a robotic surgery device
  • You or your guardian are willing and able to sign a written consent form agreeing to take part
  • You or your guardian are willing and able to follow all the requirements of the study

Who may not be able to join:

  • You have a blood clotting problem that has not been treated or corrected
  • Your medical situation requires that your surgery be done as a traditional open operation rather than a less invasive approach
  • You are considered to be in a very high-risk health category for surgery (confirm with trial site)
  • You cannot safely receive general anesthesia or undergo surgery for any reason
  • You have a significant mental health condition, intellectual disability, or serious illness that would make it difficult to follow the study requirements or give informed consent
  • You are pregnant or thought to possibly be pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (650) 724-4800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
28 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Performance; Number of Subjects With Device-related Serious Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov